EL7.AI
Stocks•16 April 2026•
1 min read

Mixed Analyst Price Target Revisions for Industrial and Healthcare Firms

Key Facts

1RBC Capital Markets raised Eaton Corporation's (ETN) price target to $457 from $439, maintaining an 'Outperform' rating.
2Truist cut Medtronic's (MDT) price target to $95 from $103, maintaining a 'Hold' rating.
3RBC made minor adjustments to price targets for W.W. Grainger (trimmed to $1,170) and Veralto (raised to $99).

Analysts from RBC Capital Markets and Truist have issued several price target revisions for major industrial and medical technology firms, reflecting a divergence in market sentiment. RBC Capital Markets raised Eaton Corporation's (ETN) price target to $457 from $439, maintaining an 'Outperform' rating based on strong sector performance. Conversely, Truist cut Medtronic's (MDT) price target to $95 from $103 while keeping a 'Hold' rating, signaling a more cautious outlook for the healthcare equipment provider. Additional minor adjustments by RBC included trimming W.W. Grainger's target to $1,170 and raising Veralto's to $99. These revisions follow the recent Q1 earnings season and reflect updated analyst outlooks based on individual company guidance. Overall, the updates present a mixed landscape, balancing bullish industrial sentiment against bearish adjustments in healthcare.